Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9648]

Romiplostim thrombopoietin receptor agonist rapidly restores platelet counts in...

Dr Frederick Chen - Barts Health NHS Trust, London, UK

Romiplostim thrombopoietin receptor agonist rapidly restores platelet counts in acute ITP in 1L treatment during COVID 19 ( Dr Frederick Chen - Barts Health NHS Trust, London, UK )

CLL TIM risk model predicts infection and treatment need in newly diagnosed...

Prof Carsten Niemann - Rigshospitalet, Copenhagen, Denmark

CLL TIM risk model predicts infection and treatment need in newly diagnosed chronic lymphocytic leukaemia ( Prof Carsten Niemann - Rigshospitalet, Copenhagen, Denmark )

Risk model predicts relapse after frontline blinatumomab in paediatric B-ALL

Prof Anthony Moorman - Newcastle University, Newcastle, UK

Risk model predicts relapse after frontline blinatumomab in paediatric B-ALL ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )

Epcoritamab induces deep and durable responses in chemotherapy-ineligible...

Prof Umberto Vitolo - Oncological Institute Candiolo, Turin, Italy

Epcoritamab induces deep and durable responses in chemotherapy-ineligible elderly patients with diffuse large B-cell lymphoma ( Prof Umberto Vitolo - Oncological Institute Candiolo, Turin, Italy )

Tafasitamab plus lenalidomide added to R-CHOP improves PFS in high-risk diffuse...

Prof Umberto Vitolo - Oncological Institute Candiolo, Turin, Italy

Tafasitamab plus lenalidomide added to R-CHOP improves PFS in high-risk diffuse large B-cell lymphoma ( Prof Umberto Vitolo - Oncological Institute Candiolo, Turin, Italy )

Brentuximab vedotin added to CHEP improves response in CD30+ peripheral T-cell...

Prof Marek Trněný - Charles University, Prague, Czechia

Brentuximab vedotin added to CHEP improves response in CD30+ peripheral T-cell lymphomas ( Prof Marek Trněný - Charles University, Prague, Czechia )

Blinatumomab replaces intensive chemo in high-risk paediatric ALL, improving...

Prof Martin Schrappe - Universitätsklinikum Schleswig-Holstein, Kiel, Germany

Blinatumomab replaces intensive chemo in high-risk paediatric ALL, improving survival ( Prof Martin Schrappe - Universitätsklinikum Schleswig-Holstein, Kiel, Germany )

Gabapentin plus tramadol reduces opioid escalation for mucositis pain in head &...

Dr Minit Shah - Tata Memorial Centre, Mumbai, India

Gabapentin plus tramadol reduces opioid escalation for mucositis pain in head & neck cancer ( Dr Minit Shah - Tata Memorial Centre, Mumbai, India )

Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck...

Dr Minit Shah - Tata Memorial Centre, Mumbai, India

Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy ( Dr Minit Shah - Tata Memorial Centre, Mumbai, India )

Understanding patient expectations and clinicians' goals in favourable risk...

Prof Daniele Santini and Dr Yann Alexandre Vano

Understanding patient expectations and clinicians' goals in favourable risk aRCC patients ( Prof Daniele Santini and Dr Yann Alexandre Vano )

STRIDE ± lenvatinib plus TACE improves outcomes in unresectable early-to...

Dr Ghassan K. Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA

STRIDE ± lenvatinib plus TACE improves outcomes in unresectable early-to-intermediate HCC ( Dr Ghassan K. Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA )

Early ctDNA clearance linked to improved outcomes in KRAS G12C-mutant...

Dr Filippo Pietrantonio - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan...

Early ctDNA clearance linked to improved outcomes in KRAS G12C-mutant colorectal cancer ( Dr Filippo Pietrantonio - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy )

More from ecancer